Translational Immunology and Nanotechnology
The TIN Theme (TINT) began in 2019, led by Dist. Prof. Magdalena Plebanski, as a world-class translational research program, driving innovation in omics/precision medicine, nanotechnology and point-of-care devices.
TINT focuses on conditions with dysregulated immunity and inflammation, across independent research groups:
TINT’s research groups each have a history of success in obtaining competitive local and international funding (e.g. ARC, NHMRC, NIH, JDRF), and collaboration with industry. They have an outstanding publication record including such journals as: The Lancet, Nature, Science, Nature Biotechnology, Immunity and Nature Medicine amongst many others. TINT labs have also successfully supervised many PhDs, who went on to great careers in academia or industry. PhD scholarships are currently available. TINT welcomes Honours and Masters student enquiries.
TINT comprises of four research groups, each led by researchers at the top of their fields.
Head: Distinguished Professor Magdalena Plebanski | Director: Biomedical & Health Innovation Enabling Impact Platform
Head: Professor Catherine Itsiopoulos | Dean, School of Health and Biomedical Sciences
To learn more about the TINT, or if you would like to discuss potential membership or collaborations, please contact TINT@rmit.edu.au
RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.
More information
